(Reuters) - CVS Caremark Corp will buy drug infusion services provider Coram LLC for $2.1 billion, allowing the company to bolster its pharmacy benefits management business by offering cost-effective ...

CVS Health plans to lay off at least 208 employees across the state in connection with the impending closure of four of its New York infusion pharmacies, according to notices filed this week with the ...

NEW YORK, Oct 11 (Reuters) - (This Oct. 11 story has been corrected to fix the spelling of the CVS executive's last name from 'Bandit' to 'Bendit' in paragraphs 3, 5, 8, 10 and 12) CVS Health (CVS.N), ...

The CVS Caremark (CVS 1.17%) acquisition of Coram Specialty Infusion Services is a good deal for investors. The leading retail-pharmacy outfit recently announced an agreement to acquire Coram from ...

CVS Health is planning to close or sell 29 regional pharmacies and discontinue its infusion services offerings, according to a statement shared with Becker’s. 1. CVS Health’s Coram will end its ...

CVS Health’s Coram is discontinuing its infusion service offerings for antibiotics, inotropic medications, total parenteral nutrition and other acute home infusion therapies and plans to close or sell ...

In an effort to develop its specialty pharmacy business, CVS Caremark (NYSE:CVS) unveiled a $2.1 billion deal on Wednesday to acquire the specialty infusion business of Apria Healthcare Group. The ...